Breaking News

Hoth Therapeutics Launches OpenClaw AI for Accelerating Drug Discovery

The platform can integrate preclinical and clinical datasets in real time, enhancing research execution.

Author Image

By: Patrick Lavery

Content Marketing Editor

Hoth Therapeutics, a clinical-stage biopharmaceutical company, is now deploying OpenClaw, its advanced, AI-enabled computational platform. OpenClaw Delivers AI Impact OpenClaw’s intent is to accelerate drug discovery, enhance data-driven decision-making, and unlock value in Hoth’s therapeutic pipeline. While Hoth did not specify products in that pipeline, the company presents itself as a “catalyst” in early-stage pharmaceutical R&D. Hoth specializes in bringing drugs from the bench ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters